Matthew Walsh has served as a Certara director since 2020 and chairs the Audit Committee. He has been Executive Vice President and CFO of Organon & Co. since June 2020, was CFO of Allergan plc from 2018 until its 2020 acquisition by AbbVie, and served as CFO of Catalent, Inc. from 2008 to 2018. He holds a B.S. in Chemical Engineering and an MBA, both from Cornell University.